by Institute of Medicine Staff, Sharyl J. Nass, Margie Patlak, Erin Balogh, Board on Health Care Services Staff
"Despite spending more time and money in developing novel therapeutics, the success rate for new pharmacologic treatments has been poor. Although the research and development expenditures have grow…